SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: A pilot study

MLA

Cohen, Ariel, et al. “SAfety of Fondaparinux in Transoesophageal Echocardiography-Guided Electric Cardioversion of Atrial Fibrillation (SAFE-AF) Study: A Pilot Study.” Archives of Cardiovascular Diseases, vol. 108, Feb. 2015, pp. 122–31. EBSCOhost, https://doi.org/10.1016/j.acvd.2014.09.009.

APA

Cohen, A., Stellbrink, C., Le Heuzey, J.-Y., Faber, T., Aliot, E., Banik, N., Kropff, S., Omran, H., Investigators, S.-A., & Davy, J.-M. (2015). SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: A pilot study. Archives of Cardiovascular Diseases, 108, 122–131. https://doi.org/10.1016/j.acvd.2014.09.009

Chicago

Cohen, Ariel, Christoph Stellbrink, Jean-Yves Le Heuzey, Thomas Faber, Etienne Aliot, Norbert Banik, Stefan Kropff, Heyder Omran, Safe-Af Investigators, and Jean-Marc Davy. 2015. “SAfety of Fondaparinux in Transoesophageal Echocardiography-Guided Electric Cardioversion of Atrial Fibrillation (SAFE-AF) Study: A Pilot Study.” Archives of Cardiovascular Diseases 108 (February): 122–31. doi:10.1016/j.acvd.2014.09.009.